Table 1.
Clinical and biochemical correlates of patients from group A and B.
| Group A | Group B | P value | |
|---|---|---|---|
| Gender (male/female), % | 51/49 | 40/60 | 1 |
| Age at PA dg (ys) | 39 (33, 44.5) | 43 (36.5, 51) | 0.29 |
| Lowest plasma K (mmol/l) | 3.2 (2.9, 3.5) | 3.1 (3.0, 3.55) | 0.78 |
| Systolic BP (mmHg) | 150 (135, 167) | 154 (143, 175) | 0.49 |
| Diastolic BP (mmHg) | 90 (82, 99) | 95 (85, 102) | 0.56 |
| Treatment score (n) | 2 (1, 3.5) | 1 (0, 2) | 0.07 |
| Urinary aldosterone (nmol/24 h) | 95 (76, 126) | 115 (87.5, 153.5) | 0.57 |
| Plasma aldosterone (pmol/l) | 845 (508, 1127) | 1168 (633.5, 1797) | 0.32 |
| Plasma renin (mU/l) | 2.2 (1.4, 4.3) | 1.7 (1.2, 3.4) | 0.42 |
| ARR (pmol/mU) | 271.8 (179.8, 602.5) | 831.0 (385.5, 1152) | 0.16 |
| Adenoma size (mm) | 14.5 (9.0, 18.0) | 40 (32.0, 52.5) | <0.0001 |
| Systolic BP at FU (mmHg) | 131 (120, 149) | 116 (112, 142) | 0.31 |
| Diastolic BP at FU (mmHg) | 84 (80, 96) | 73 (72, 94) | 0.34 |
| Treatment score at FU (n) | 0 (0, 2) | 0 (0, 2) | 0.63 |
| Plasma K at FU (mmol/l) | 4.1 (3.8, 4.3) | 4.0 (3.6, 4.2) | 0.45 |
| Plasma aldosterone at FU (pmol/l) | 130 (85, 251) | 74 (36, 200) | 0.15 |
| Plasma renin at FU (mU/l) | 11.0 (6.8, 17.2) | 9.0 (7.9, 101.3) | 0.80 |
| ARR at FU (pmol/mU) | 14.1 (7.0, 17.8) | 9.0 (7.9, 101.3) | >0.99 |
PA: primary aldosteronism; HTN: hypertension; K: potassium; BP: blood pressure; ARR: aldosterone to renin ratio; FU: follow-up.
Categorical data reported as number (percentage) and compared with Fischer’s exact test; quantitative data reported as median (interquartile range) and compared with the Mann-Whitney test (p significant if <0.05).